#PortfolioNews I We're proud to share that we have joined the oversubscribed $135M Series B financing of our #portfolio company #Adcendođź‘Ź
🎯Developing breakthrough #ADCs, for the #treatment of underserved #cancers
👉Full details https://buff.ly/3Z3JfYm
#vc #oncology #Innovation #biotech #Europe #investment
🎯Developing breakthrough #ADCs, for the #treatment of underserved #cancers
👉Full details https://buff.ly/3Z3JfYm
#vc #oncology #Innovation #biotech #Europe #investment
Comments